HR Execs on the Move

Flexion Therapeutics

www.flexiontherapeutics.com

 
Flexion Therapeutics (NASDAQ: FLXN) is a biopharmaceutical company focused on the discovery, development & commercialization of novel, local therapies for the treatment of patients with musculoskeletal conditions. Flexion is based in Burlington, Massachusetts.
  • Number of Employees: 250-1000
  • Annual Revenue: $50-100 Million

Executives

Name Title Contact Details
Derek Jackson
Vice President, Product Development Profile
Bryan Drum
Sr. Director Marketing Profile

Jobs

Vice President, Human Resources

Flexion Therapeutics Burlington, MA
http://flexiontherapeutics.com/careers/

Similar Companies

Carlinville Area Hospital Association, Inc

Carlinville Area Hospital Association, Inc is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Carlinville, IL. To find more information about Carlinville Area Hospital Association, Inc, please visit www.cahcare.com

Validation Technologies

Validation Technologies is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

American Institute of Gastric Banding

AIGB specializes in LAP-BAND surgery, an FDA-approved weight-loss surgery available to overweight and obese individuals. AIGB also provides a comprehensive, multi-disciplinary aftercare program to ensure the success of our LAP-BAND patients. Our

Versartis

Versartis, Inc. (NASDAQ: VSAR) is an endocrine-focused biopharmaceutical company developing novel, long-acting medicines to transform treatment for patients with endocrine disorders. The company is led by a management team with rich experience and expertise discovering, developing and commercializing innovative therapeutics for the life sciences industry. Versartis` mission is to develop, manufacture and commercialize novel therapeutics to improve and transform treatment for patients with orphan endocrine disorders. Versartis is well-positioned to deliver a major innovation to the global growth hormone deficiency (GHD) market with the company`s most advanced clinical candidate, somavaratan. Somavaratan is a novel, long-acting form of recombinant human growth hormone that is in global late-stage clinical trials to treat GHD in children and adults. Twice-monthly somavaratan is intended to reduce the burden of daily injection therapy by requiring significantly fewer injections, potentially improving compliance/adherence and treatment outcomes.

Denver-Vail Orthopedics

Denver-Vail Orthopedics is a Denver, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.